US FDA Approves ZYCUBO for Menkes Disease; Cyprium to Receive Milestones & Royalties

• ZYCUBO approved for Menkes disease treatment in US • First approved treatment for rare pediatric disease • Rare Pediatric Disease Priority Review Voucher granted • Cyprium eligible for royalties and $129 million in milestones • FDA approval marks significant milestone for Cyprium and Fortress Biotech